The story
Slovakia removed cannabidiol, or CBD, from its psychotropic-substance list on 1 May 2021.[1] Parliament’s amendment deleted the entry naming CBD, changing the substance’s position under the controlled-drug law.[1]
Parliament deleted the named substance
The National Council approved the amendment on 18 March 2021, and it was published on 9 April before taking effect in May.[1] The operative provision removed the cannabidiol entry from the second group of psychotropic substances.[1]
The amendment worked through the existing controlled-substances statute, which separately regulates authorisations, cultivation, production and handling.[1][2] Cannabis and THC remained covered by their own entries and rules.[2] For growers, the relevant permissions therefore continued to depend on the plant, variety and purpose involved.[2]
Hemp cultivation retained its own rules
The current statute permits industrial growing for obtaining fibre and seed, alongside a separate research route.[2] Varieties listed in the EU common catalogue, including varieties listed when they were sown, are exempt from the ordinary Health Ministry cultivation permit.[2]
Other cultivation and processing need permission, with safeguards against diversion.[2] A cultivation permit ordinarily lasts one year, and permit holders must hand the harvest to a processing organisation or destroy the remaining material under supervision.[2] These conditions govern how plants and harvests move through authorised production.[2]
Food and medicines followed different assessments
The Agriculture Ministry’s February 2026 notice explains that CBD is treated as a novel food under EU rules.[3] It reports EFSA’s temporary intake benchmark while emphasising gaps in the available safety evidence.[3] Food classification and safety assessment therefore remained relevant after the controlled-substance deletion.[3]
A separate 2023 NIHO assessment evaluated the purified CBD medicine Epidyolex with clobazam for Dravet and Lennox-Gastaut syndromes from age two.[4] That report considered clinical and economic evidence for a particular treatment and patient group.[4]
Later controls covered other cannabinoids
Slovakia added HHC and related cannabinoids to its drug schedules in November 2024.[5] The amendment named substances individually, including HHC, HHC-O and HHC-P.[5] It also revised authorisation and hemp-cultivation provisions within the controlled-substances law.[5]
The Slovakia profile follows these separate rules for controlled cannabis, industrial hemp, CBD and licensed research.[2][5]
In the cultural atlas
Listed for context. No score change is recorded for Slovakia here.
References
- Slov-Lex — Act 124/2021Article I point 32 and commencementarchived
- Slov-Lex — Controlled Substances Act 139/1998, January 2026 consolidationSection 15 and schedulesarchived
- Slovak Agriculture Ministry — CBD novel-food safety notice, 20 February 2026archived
- NIHO — Cannabidiol/Epidyolex assessment 37A/2023archived
- Slov-Lex — Act 246/2024Controlled cannabinoids and commencementarchived
Checked. The date and the event were compared with a source that was read.
